Maia Drug Patent Portfolio
Maia owns 3 orange book drugs protected by 10 US patents Given below is the list of Maia's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11679119 | Bortezomib compositions | 23 Sep, 2042 | Active |
| US11752164 | Bortezomib compositions | 23 Sep, 2042 | Active |
| US12005069 | Bortezomib compositions | 23 Sep, 2042 | Active |
| US11903993 | Ready-to-use bivalirudin compositions | 20 May, 2039 | Active |
| US11918622 | Ready-to-use bivalirudin compositions | 20 May, 2039 | Active |
| US11992514 | Ready-to-use bivalirudin compositions | 20 May, 2039 | Active |
| US12472224 | 20 May, 2039 | Active | |
| US11110063 | Storage stable sincalide formulations | 20 Apr, 2038 | Active |
| US11318100 | Storage stable sincalide formulations | 20 Apr, 2038 | Active |
| US11737983 | Storage stable sincalide formulations | 20 Apr, 2038 | Active |
Latest Legal Activities on Maia's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Maia.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Sequence Moved to Public Database | 15 Mar, 2024 | US11918622 |
| Patent eGrant Notification | 05 Mar, 2024 | US11918622 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Mar, 2024 | US11918622 |
|
Recordation of Patent Grant Mailed
Critical
| 05 Mar, 2024 | US11918622 |
|
Email Notification
Critical
| 05 Mar, 2024 | US11918622 |
| Recordation of Patent eGrant | 05 Mar, 2024 | US11918622 |
| Mail Patent eGrant Notification | 05 Mar, 2024 | US11918622 |
| Sequence Moved to Public Database | 29 Feb, 2024 | US11903993 |
|
Recordation of Patent Grant Mailed
Critical
| 20 Feb, 2024 | US11903993 |
| Mail Patent eGrant Notification | 20 Feb, 2024 | US11903993 |
| Patent eGrant Notification | 20 Feb, 2024 | US11903993 |
|
Email Notification
Critical
| 20 Feb, 2024 | US11903993 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Feb, 2024 | US11903993 |
| Recordation of Patent eGrant | 20 Feb, 2024 | US11903993 |
|
Email Notification
Critical
| 15 Feb, 2024 | US11918622 |
Maia's Family Patents
Maia Drug List
Given below is the complete list of Maia's drugs and the patents protecting them.
1. Angiomax Rtu
Angiomax Rtu is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11903993 | Ready-to-use bivalirudin compositions |
20 May, 2039
(13 years from now)
| Active |
| US11918622 | Ready-to-use bivalirudin compositions |
20 May, 2039
(13 years from now)
| Active |
| US11992514 | Ready-to-use bivalirudin compositions |
20 May, 2039
(13 years from now)
| Active |
| US12472224 |
20 May, 2039
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Angiomax Rtu's drug page
2. Bortezomib
Bortezomib is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11679119 | Bortezomib compositions |
23 Sep, 2042
(16 years from now)
| Active |
| US11752164 | Bortezomib compositions |
23 Sep, 2042
(16 years from now)
| Active |
| US12005069 | Bortezomib compositions |
23 Sep, 2042
(16 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Bortezomib's drug page
3. Sincalide
Sincalide is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11110063 | Storage stable sincalide formulations |
20 Apr, 2038
(12 years from now)
| Active |
| US11318100 | Storage stable sincalide formulations |
20 Apr, 2038
(12 years from now)
| Active |
| US11737983 | Storage stable sincalide formulations |
20 Apr, 2038
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sincalide's drug page